ALHC · NASDAQ · STOCK
Alignment Healthcare, Inc.
$13.18
52W $13.05 – $25.12
54/100
$2.74B
66.2
1.10
Is ALHC Bullish or Bearish?
Mixed.
Innellis AI committee rates Alignment Healthcare, Inc. (ALHC) Watch with a composite score of 54/100
, based on 6 analysts with 50% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +5.75 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -14.25 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Growth Analyst sees a compelling case — revenue growing 37.2% yoy -- genuine top-line momentum. Risk Analyst remains cautious — high leverage (debt-to-equity 1.80) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- ROE of 20.0% shows genuine earnings power backing the valuation — Value
- Revenue growing 37.2% YoY -- genuine top-line momentum — Growth
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 70.2 is expensive by classic value standards — Value
- Price-to-book of 22.0x prices in significant intangible value — Value
- Debt-to-equity of 1.80 adds balance-sheet risk to the value case — Value
- Price structure making lower highs and lower lows — Technical
- RSI at 23 is in oversold territory (could mean either capitulation or a bounce setup) — Technical
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
54/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 88%
of 192 Healthcare peers
Value Analyst
bearish
40
/ 100 · High confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
+ ROE of 20.0% shows genuine earnings power backing the valuation
− P/E of 70.2 is expensive by classic value standards
Growth Analyst
bullish
85
/ 100 · Low confidence
Strong, accelerating growth with consistent execution
+ Revenue growing 37.2% YoY -- genuine top-line momentum
Technical Analyst
bearish
33
/ 100 · High confidence
Price action is deteriorating -- trend and/or momentum are working against this name
− Price structure making lower highs and lower lows
Risk Analyst
bearish
32
/ 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 1.80) amplifies downside in a stress scenario
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
neutral
58
/ 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
23.3
Oversold
MACD Histogram
-0.487
Bearish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Hh Hl
Support
$13.05
Resistance
$21.05
Bollinger %B
0.16
Inside Bands
Price vs Moving Averages
EMA 9
$14.69
Below
EMA 21
$16.75
Below
EMA 50
$18.32
Below
EMA 200
$18.59
Below
Fundamental Analysis
Valuation
33
Profitability
1
Financial Health
69
Cash Flow
70
Valuation
P/E Ratio
66.2×
P/B Ratio
10.33×
PEG Ratio
0.00
Dividend Yield
0.00%
52W High
$25.12
52W Low
$13.05
Quality & Growth
ROE
-40.4%
ROA
-6.8%
Gross Margin
1254.9%
Operating Margin
120.2%
Revenue Growth YoY
—
Debt / Equity
1.25
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 66.2 (rich relative to a 15-40x range); Price-to-book of 10.3x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.4%; Return on assets of -0.1%; Net margin of 0.9%; Gross margin of 12.5%; Current ratio of 1.70 (healthy short-term liquidity); Debt-to-equity of 1.25; Free cash flow per share is positive (0.99); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full ALHC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →